A Case of a man with relentless headache

Post on 22-Feb-2016

40 views 0 download

Tags:

description

A Case of a man with relentless headache. Calma * Capili * Dagang * Dayrit. General Data. FV 49/M Married, Roman Catholic, from Canlubang Laguna Admitted to the PGH ER last April 2, 2010. Chief Complaint. Headache for 5 months. History of Present Illness. - PowerPoint PPT Presentation

transcript

A Case of a man with relentless headache

Calma * Capili * Dagang * Dayrit

General DataFV49/MMarried, Roman Catholic, from

Canlubang LagunaAdmitted to the PGH ER last April 2,

2010

Chief ComplaintHeadache for 5 months

History of Present Illness

History of Present Illness

(+) weight loss (25% in 5 months)

(-) anorexia(-) fever(-) cough, colds(-) difficulty of

breathing(-) chest pain

Review of Systems(-) abdominal pain(+) 3 P’s(-) bowel complaints(-) seizures(-) loss of

consciousness(-) edema

Past Medical History(+) HPN – since 2000, UBP 160/100,

HBP 180/120, (-) maintenance medications

(+) DM – since 2003, (-) maintenance medications

(-) PTB, BA, allergies, history or trauma, previous surgeries

Family Medical History(+) HPN – father(-) DM, PTB, BA, CA

Personal Social HistoryTruck driver, married with 6 childrenNon-smoker, occasional alcoholic

beverage drinker, (-) illicit drug use

Physical ExaminationBP 130/90 HR 90 RR 20PC, AS, (-) CLAD, (-) ANMECE, CBS, (-)crackles/wheezes(-) heaves/thrills, DHS, NRRR, AB 5th

ICS LAAL, (-) murmursAbdomen flat, NABS, soft, non-tenderFEP, PNB, (-) clubbing, (-) edema

Neurologic ExaminationGCS 15, alert, awake, oriented to 3

spheresCranial NervesI Not assessed

II Pupils 3 mm EBRTL, VA: OD 20/40, OS 20-40-2, (-) visual field cuts

III, IV, VI

(+) LR palsy OS

V V1: R 100% L 10%; V2: R 100% L 10%; V3: B 100%

VII Shallow L NLF, (+) L central facial palsy VIII Webber: Lateralized to the L, Rinne: AS:

BC>ACIX, X Good gagXI Good shoulder shrugXII Tongue midline

Neurologic ExaminationMotor

Good muscle bulk, (-) spasticity, (-) flaccidity

5/5 5/5

5/5 5/5Sensory

100% 100%

100% 100%

Neurologic Examination DTRs

++ ++

++ ++

++ ++

Cerbellars: (-) dysmetria, (-) dystiadochokinesia Meningeals: (-) nuchal rigidity, (-) Kernig’s, (-) Brudzinski Autonomic

Cranial CT Scan(+) contrast enhancing tumor, ill

defined involving sellar-supresellar, sphenoidal areas

Cranial CT ScanInsert plates here

Cranial MRI with GAD(+) sellar-supresellar mass occupying

the sphenoid sinus as well(+) encasing B cavernous sinus with

invasion of clivusImpression: Chordoma vs. Invasive

Pituitary Adenoma

Cranial MRI with GADInsert plates here

Other Laboratory ExamsCBC: 4/2: Hgb 103 Hct 0.309 WBC

7.1 N 0.652 L 0.276 Plt 331PT/PTT: 4/2: 11.0/12.2/0.89/1.17;

32.6/37.34/5: FT4 8.4 (N 11-24 pmol/L), TSH

0.8 (N 0.3-3.8 mIU/L), Cortisol 25 (N 138-690 nmol/L), PRL 3,041.9 (80-430mIU/L)

Other Laboratory Exams

4/2 4/3 4/6 4/10 4/12 4/16 4/19Glucose 11.8 10.3

BUN 6.79 5.77 2.46

Crea 117 124 108

Na 127 127 126 126 119 115 132

K 4.1 4 4 4.1 4 3.4

Cl 88 90 90 85 72

Ca 2.23 1.97

Mg 0.68

Urine Na 238

Urine K 11.6

Urine Cl 213

Course in the ERIn the ER, pt managed primarily by

NSS, co-managed by ORL, Ophtha, and Endo

Pt GCS 15 while in the ER, no motor or sensory deficits.

Pt on the following medications: Mannitol 75 cc IV Q8 Q6, Celecoxib 200 mg/cap Q12, Tramadol 50 mg/tab TID Tramadol 50 mg IV Q8, Ketorolac drip (30 mg in 250cc D5W x 24h), Dexamethasone 5 mg/IV Q6

Course in the ERORL: A> hearing loss etiology to be

determined. Plan for PTA-ST and for transsphenoidal biopsy/GA once admitted

Ophtha: A> LR palsy probably secondary to malignancy. Refraction done. Plan for visual perimetry.

Course in the EREndo: A> Consider secondary hypogonadism,

secondary hypothyroidism, secondary hypoadrenalism secondary to suprasellar mass with mass effect. Hyperglycemia probably secondary to DM vs. steroid induced vs. combination. Hyponatremia secondary to SIADH due to tumor, secondary hypothyroidism, secondary to AI, secondary to mannitol use, orsecondary to hyperglycemia. Pt started on Levothyroxine 100 mcg/tab 30 min before breakfast, HN 20-0-10 SQ pre-melas, HR 8-8-8 SQ pre-meals, defer for CBG < 70mg/dL.